COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core

Juhn, 2008, The role of inflammatory mediators in the pathogenesis of otitis media and sequelae, Clin. Exp. Otorhinolaryngol., 1, 117, 10.3342/ceo.2008.1.3.117 Barbey, 2002, Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor, Bioorg. Med. Chem. Lett., 12, 779, 10.1016/S0960-894X(02)00013-6 Charlier, 2003, Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipooxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs, Eur. J. Med. Chem., 38, 645, 10.1016/S0223-5234(03)00115-6 Abdelall, 2016, Synthesis of new thiazolo-celecoxib analogues as dual cyclooxygenase-2/15-lipoxygenase inhibitors: Determination of regio-specific different Pyrazole Cyclization by 2D NMR, Eur. J. Med. Chem., 118, 250, 10.1016/j.ejmech.2016.04.049 Allison, 1992, Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs, N. Engl. J. Med., 327, 749, 10.1056/NEJM199209103271101 Perrone, 2015, Selective cyclooxygenase-1 inhibition by P6 and gastrotoxicity: Preliminary investigation, Pharmacology, 95, 22, 10.1159/000369826 Tanaka, 2002, Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: A key to nonsteroidal anti-inflammatory drug-induced intestinal damage, J. Pharmacol. Exp. Ther., 300, 754, 10.1124/jpet.300.3.754 Micklewright, 2003, NSAIDs, gastroprotection and cyclooxygenase-II-selective inhibitors, Aliment. Pharmacol. Ther., 17, 321, 10.1046/j.1365-2036.2003.01454.x Jackson, 2000, COX-2 selective nonsteroidal anti- inflammatory drugs: do they really offer any advantages?, Drugs, 59, 1207, 10.2165/00003495-200059060-00001 Abdelazeem, 2014, Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; Design, synthesis and biological evaluation as potential anti-inflammatory agents, Eur. J. Pharm. Sci., 62, 197, 10.1016/j.ejps.2014.05.025 Karoui, 2014, Synthesis and pharmacological evaluation of pyrazolopyrimidopyrimidine derivatives: Anti-inflammatory agents with gastroprotective effect in rats, Med. Chem. Res., 23, 1591, 10.1007/s00044-013-0742-x Ferrari, 2016, Pyrazolopyrimidine derivatives as antineoplastic agents: with a special focus on thyroid cancer, Mini Rev. Med. Chem., 16, 86, 10.2174/1389557515666151016124208 Kandeel, 2013, Design, synthesis and cytotoxic activity of some novel compounds containing pyrazolo [3,4-d] pyrimidine nucleus, Der Pharma Chem., 5, 109 Bakr, 2012, Design and synthesis of new EGFR-tyrosine kinase inhibitors containing pyrazolo[3,4-d]pyrimidine cores as anticancer agents, Bull. Pharm. Sci. Assiut Univ., 35, 1 Trivedi, 2012, Synthesis and anti-tubercular evaluation of some novel pyrazolo[3,4-d]pyrimidine derivatives, Med. Chem. Res., 21, 1887, 10.1007/s00044-011-9712-3 Siddiqui, 2014, 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents, Bioorg. Med. Chem. Lett., 24, 1493, 10.1016/j.bmcl.2014.02.012 El-Sayed, 2017, Synthesis and antimicrobial activity of newly synthesized 4-substituted-pyrazolo [3,4-d] pyrimidine derivatives, Med. Chem. Res., 26, 1107, 10.1007/s00044-017-1814-0 Elkalyoubi, 2016, A novel synthesis of fused uracils: indenopyrimidopyridazines, pyrimidopyridazines, and pyrazolopyrimidines for antimicrobial and antitumor evalution, Molecules, 21, 1 Yewale, 2012, Novel 3- substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents, Bioorg. Med. Chem. Lett., 22, 6616, 10.1016/j.bmcl.2012.08.119 Devesa, 2004, A new pyrazolo pyrimidine derivative inhibitor of cyclooxygenase-2 with anti-angiognic activity, Eur. J. Pharmacol., 488, 225, 10.1016/j.ejphar.2004.02.015 Abdelall, 2016, Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY, Bioorg. Med. Chem. Lett., 123, 803 Inceler, 2018, Design, synthesis and biological evaluation of novel 1,3-diarylpyrazoles as cyclooxygenase inhibitors, antiplatelet and anticancer agents, Med. Chem. Commun., 9, 795, 10.1039/C8MD00022K Kharb, 2011, Pharmacological significance of triazole scaffold, J. Enzyme Inhib. Med. Chem., 26, 1, 10.3109/14756360903524304 Lamie, 2015, Design, synthesis and evaluation of novel phthalimide derivatives as in vitro anti-microbial, anti-oxidant and anti-inflammatory agents, Molecules, 20, 16620, 10.3390/molecules200916620 Dheer, 2017, Medicinal attributes of 1,2,3-triazoles: Current developments, Bioorg Chem., 71, 30, 10.1016/j.bioorg.2017.01.010 Abd El-Samii, 1992, Synthesis and anti-inflammatory activity of some novel 1,3,4- oxadiazole derivatives, J. Chem. Tech. Biotechnol., 53, 143, 10.1002/jctb.280530206 El-Moghazy, 2012, Synthesis and anti-inflammatory activity of some pyrazole derivatives, Med. Chem. Res., 21, 1722, 10.1007/s00044-011-9691-4 Rakesh, 2015, Schiff“s bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants, Bioorg. Med. Chem. Lett., 25, 1072, 10.1016/j.bmcl.2015.01.010 Lamie, 2016, Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5- lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study, Eur. J. Med. Chem., 26, 2893 Abdellatif, 2017, Nitric oxide-NASIDS donor prodrugs as hybrid safe anti-inflammatory agents, Curr. Top. Med. Chem., 17, 941, 10.2174/1568026616666160927153435 Abdelall, 2017, Synthesis and biological evaluation of new nitric oxide-anti-inflammatory drug hybrids, Bioorg. Med. Chem. Lett., 27, 4358, 10.1016/j.bmcl.2017.08.023 Kandeel, 2013, Synthesis of some novel thieno[3,2-d]pyrimidines as potential cytotoxic small molecules against breast cancer, Chem. Pharm. Bull., 61, 637, 10.1248/cpb.c13-00089 Elshemy, 2017, Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC, Eur. J. Med. Chem., 127, 10, 10.1016/j.ejmech.2016.12.030 Tominaga, 1990, Synthesis of pyrazolo[3,4-d]pyrimidine derivatives using ketene dithioacetals, J. Heterocyclic chem., 27, 775, 10.1002/jhet.5570270355 Abd El Hamid, 2012, Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents, Eur. J. Med. Chem., 57, 323, 10.1016/j.ejmech.2012.09.031 http://www.rcsb.org/pdb/explore/explore.do?structureId=1CX2. Kurumbail, 1996, Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents, Nature, 384, 644, 10.1038/384644a0